Abstract
Since the implementation of centralized drug procurement organized by the state, the calculation of surplus funds has a very important incentive effect on medical institutions. Combined with the actual work of Anhui Province, this paper simulates and calculates the relevant parameters and indicators, classifies and analyzes the different reported volume of various medical institutions, and finally obtains some suggestions. When reporting the volume, medical institutions can appropriately float up the agreed purchase volume base, and guide patients to minimize the use of non winning products or non winning drugs whose purchase price is lower than the winning price, so as to maximize the remaining funds of various varieties..
Key words
national centralized drug procurement /
medical insurance funds /
retention of surplus funds /
index analysis
Cite this article
Download Citations
Yang Shuo, Li Yu, Hu Jian.
Analysis on Relevant Indicators of Retention Policy of Centralized Drug Purchase[J]. China Health Insurance. 2022, 0(3): 68-70 https://doi.org/10.19546/j.issn.1674-3830.2022.3.013
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 国家医保局.关于国家组织药品集中采购工作中医保资金结余留用的指导意见[S].医保发〔2020〕 26 号.
[2] 安徽省医保局.关于贯彻落实国家组织药品集中采购工作中医保资金结余留用政策的实施意见[S].皖医保秘〔2020〕 88 号.
[3] 王震. 集采药品结余留用的政策逻辑[J].中国卫生,2020(09):92-93.
[4] 国家药品集采三批过后看趋势[N].健康报,2020-08-31(007).
[5] 宁艳阳. 结余留用政策的落地猜想[J].中国卫生,2020(10):108-109.